News

NSAIDs Associated With Cardiovascular Risk


 

For now, naproxen seems to be the safest NSAID in terms of cardiovascular risk.

With any NSAID, consider also prescribing gastroprotective drugs.

NSAIDs are not the only option for treatment of musculoskeletal symptoms. Clinicians also prescribe paracetamol, low-dose opioid analgesics, and newer drugs, but without large-scale comparison studies, it's impossible to tell which is best for both efficacy and safety, Dr. Ray wrote. “Perhaps it is time for a larger, more systematic evaluation of a broader range of alternatives,” he suggested.

DR. WAYNE A. RAY is a professor and director of pharmacoepidemiology at Vanderbilt University, Nashville, Tenn. Dr. Ray has received financial support from Pfizer, was a paid expert witness in a lawsuit by the state of Texas against Merck, and is a paid expert in an insurance company action against the maker of Prempro.

Pages

Recommended Reading

Back Pain in Adults Could Be Spondyloarthritis
MDedge Rheumatology
Arthrodesis Seems to Be Effective in Midfoot Arthritis
MDedge Rheumatology
Foot Deformities Usually Are Correctable With Early Action
MDedge Rheumatology
Heart Disease in RA Has Complex Etiology
MDedge Rheumatology
Methotrexate Use in RA Shown to Be Protective Against Mortality
MDedge Rheumatology
TNF Inhibitor Users Report Less Sick Leave
MDedge Rheumatology
Remission Becoming a Reachable Goal in RA : Strategies now include intensive management, treatment to target, and combined DMARDs.
MDedge Rheumatology
TNF Inhibitors Appear to Reduce Diabetes Risk in RA
MDedge Rheumatology
Evidence for Smoking–Severe RA Link Bolstered
MDedge Rheumatology
Elderly With Arthritis: Opioids Riskier Than Other Analgesics
MDedge Rheumatology